Mitchell Sinkler & Starr Pfizer Inc Transaction History

Mitchell Sinkler & Starr

$387 Million
Q2 2024

A detailed history of Mitchell Sinkler & Starr transactions in Pfizer Inc stock. As of the latest transaction made, Mitchell Sinkler & Starr holds 27,602 shares of PFE stock, worth $805,978. This represents 0.2% of its overall portfolio holdings.

Number of Shares

27,602

Previous 39,891 30.81%

Holding current value

$805,978

Previous $1.11 Million 30.2%

% of portfolio

0.2%

Previous 0.28%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	SELL	$25.26 - $29.6 $310,420 - $363,754	-12,289 Reduced 30.81%	27,602 $772,000
Q1 2024 Apr 30, 2024	SELL	$25.89 - $29.73 $1.21 Million - $1.38 Million	-46,564 Reduced 53.86%	39,891 $1.11 Million
Q4 2023 Feb 12, 2024	BUY	$26.13 - $33.94 $646,247 - $839,404	24,732 Added 40.07%	86,455 $2.49 Million
Q3 2023 Nov 01, 2023	BUY	$32.09 - $37.51 $832,992 - $973,684	25,958 Added 72.58%	61,723 $2.05 Million
Q2 2023 Jul 18, 2023	SELL	$36.12 - $41.79 $42,260 - $48,894	-1,170 Reduced 3.17%	35,765 $1.31 Million
Q1 2023 May 15, 2023	SELL	$39.39 - $51.28 $286,444 - $372,908	-7,272 Reduced 16.45%	36,935 $1.51 Million
Q4 2022 Feb 14, 2023	BUY	$41.75 - $54.5 $766,780 - $1 Million	18,366 Added 71.07%	44,207 $2.27 Million
Q3 2022 Oct 25, 2022	SELL	$43.76 - $53.42 $10,283 - $12,553	-235 Reduced 0.9%	25,841 $1.13 Million
Q2 2022 Jul 21, 2022	SELL	$46.53 - $55.17 $21,869 - $25,929	-470 Reduced 1.77%	26,076 $1.37 Million
Q1 2022 Apr 19, 2022	BUY	$45.75 - $56.69 $217,038 - $268,937	4,744 Added 21.76%	26,546 $1.37 Million
Q4 2021 Feb 01, 2022	SELL	$41.32 - $61.25 $23,924 - $35,463	-579 Reduced 2.59%	21,802 $1.29 Million
Q1 2021 Apr 12, 2021	BUY	$33.49 - $37.77 $70,329 - $79,317	2,100 Added 10.35%	22,381 $811,000
Q4 2020 Feb 09, 2021	SELL	$33.47 - $42.56 $30,959 - $39,368	-925 Reduced 4.36%	20,281 $747,000
Q4 2019 Jan 09, 2020	SELL	$32.92 - $37.36 $23,208 - $26,338	-705 Reduced 3.22%	21,206 $831,000
Q3 2019 Nov 06, 2019	SELL	$32.49 - $42.13 $64,980 - $84,260	-2,000 Reduced 8.36%	21,911 $787,000
Q2 2019 Jul 17, 2019	SELL	$36.98 - $41.52 $40,678 - $45,672	-1,100 Reduced 4.4%	23,911 $1.04 Million
Q1 2019 Apr 08, 2019	SELL	$37.5 - $41.2 $90,300 - $99,209	-2,408 Reduced 8.78%	25,011 $1.06 Million
Q4 2018 Jan 24, 2019	SELL	$38.47 - $43.86 $8,848 - $10,087	-230 Reduced 0.83%	27,419 $1.2 Million
Q3 2018 Oct 04, 2018	BUY	$34.47 - $41.81 $58,599 - $71,077	1,700 Added 6.55%	27,649 $1.22 Million
Q2 2018 Jul 11, 2018	BUY	$32.98 - $35.16 $8,442 - $9,000	256 Added 1.0%	25,949 $941,000
Q1 2018 Apr 13, 2018	BUY	$31.91 - $37.02 $201,224 - $233,448	6,306 Added 32.53%	25,693 $912,000
Q4 2017 Jan 11, 2018	BUY	$33.26 - $35.29 $33,260 - $35,290	1,000 Added 5.44%	19,387 $702,000
Q3 2017 Oct 23, 2017	BUY	$31.0 - $34.15 $569,997 - $627,916	18,387	18,387 $656,000

Others Institutions Holding PFE

# of Institutions

3,219

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $164B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitchell Sinkler & Starr, based on Form 13F filings with the SEC.

News

Stay updated on Mitchell Sinkler & Starr with notifications on news.

Account

Mitchell Sinkler & Starr Pfizer Inc Transaction History